Drug
lanadelumab-flyo
Marketed as TAKHZYRO.
Generic name
lanadelumab-flyo
Brand names
TAKHZYRO
First FDA approval
2018-08-23
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761090 | TAKHZYRO | 2018-08-23 | DYAX CORP. |
Manufacturers
DYAX CORP.
Frequently asked questions
When was lanadelumab-flyo FDA approved?
Earliest FDA approval on record: 2018-08-23.
What brand names are sold as lanadelumab-flyo?
TAKHZYRO.
Sources
Appeal a lanadelumab-flyo denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com